Hee Sung Park

Prof. Hee Sung Park

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2007 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
SKSu-Sung Kim
Su-Sung Kim
DSDong-Il Shin
Dong-Il Shin
HPHee Sung Park
Hee Sung Park

1 May 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HPHee Sung Park
Hee Sung Park
NJNam Ho Jeoung
Nam Ho Jeoung

1 January 2024 in Discovery Medicine
Verified
Journal Article
Open access
PDF file
SKSe Gie Kim
Se Gie Kim
TDThanh Van Duong
Thanh Van Duong
SLSemin Lee
Semin Lee
KRKi-Jun Ryu
Ki-Jun Ryu
HKHyuk-Kwon Kwon
Hyuk-Kwon Kwon
HPHee Sung Park
Hee Sung Park
Background: Anti-cancer peptides are a powerful drug concept that induces cancer cell death through growth inhibition and membrane disruption, providing broad efficacy. The autocrine motility factor (AMF) interacts with the AMF receptor, regulating cancer cell motility, proliferation, metastasis, and angiogenesis through autocrine and paracrine pathways. However, studies verifying the synergistic effect of the combined use of anti-cancer drugs extracted from plants and AMF treatment are insufficient. Methods: The effects of AMF-derived peptide sequences were evaluated in HT29 and SW620 colorectal cancer (CRC) cell lines. The study assessed the impact of AMF peptides on cell proliferation, colony formation, the Nicotinamide Adenine Dinucleotide Phosphate/Reduced Nicotinamide Adenine Dinucleotide Phosphate (NADP+/NADPH) ratio, and reactive oxygen species (ROS) generation in these CRC cells. Additionally, the combined effect of AMF peptides and glycyrrhetinic acid (GA), a compound derived from licorice plants, was investigated by analyzing cell proliferation, colony formation, ROS production, and cell cycle progression in CRC cells. Results: AMF peptides significantly inhibited CRC cell growth (p < 0.05), decreased colony formation (p < 0.05), and increased the NADP+/NADPH ratio (p < 0.05) and ROS production (p < 0.001). When combined with GA, AMF peptides enhanced GA's effects on CRC cells, further suppressing cell growth (p < 0.05) and colony formation (p < 0.05) while increasing ROS generation (p < 0.05). Conclusion: The synergy between AMF peptides and GA, derived from licorice plants, suggests the potential for combined peptide-phytochemical therapy for treating CRC.

1 June 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NJNam Ho Jeoung
Nam Ho Jeoung
AJAe Lim Jo
Ae Lim Jo
HPHee Sung Park
Hee Sung Park

6 November 2014 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
DSDong-Il Shin
Dong-Il Shin
KSKyu-Seon Song
Kyu-Seon Song
HPHee Sung Park
Hee Sung Park

15 December 2023 in Applied Biological Chemistry
Verified
Journal Article
Open access
PDF file
SKSeok Joong Kim
Seok Joong Kim
YKYangji Kim
Yangji Kim
TDThanh Van Duong
Thanh Van Duong
HPHee Sung Park
Hee Sung Park
Colorectal cancer (CRC) presents a formidable challenge, characterized by a steadily increasing incidence. Current approaches to manage CRC, including chemotherapy and targeted therapies, are burdened with significant limitations such as resistance development, adverse events, and high costs. Hence, there is an urgent demand for a more promising alternative. Autocrine motility factor (AMF), known for its role in promoting cancer cell motility, exhibits a unique ability to selectively impede the growth of cancer cells. In our study, we have elucidated the specific inhibitory effect of AMF derived from DU145 prostate cancer cells (D-AMF) on the proliferation of CRC cells. D-AMF effectively downregulated the expression of glucose-6-phosphate dehydrogenase (G6PD) at both the mRNA and protein levels, resulting in a concurrent increase in the generation of reactive oxygen species (ROS). Notably, the combination of D-AMF and curcumin proved highly effective in eliminating curcumin-resistant CRC cells. Therefore, the use of D-AMF in conjunction with curcumin holds promise as an alternative treatment approach for CRC.